192 related articles for article (PubMed ID: 18852883)
1. Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence.
Palmeira VF; Kneipp LF; Rozental S; Alviano CS; Santos AL
PLoS One; 2008; 3(10):e3382. PubMed ID: 18852883
[TBL] [Abstract][Full Text] [Related]
2. HIV Aspartic Peptidase Inhibitors Modulate Surface Molecules and Enzyme Activities Involved with Physiopathological Events in
Palmeira VF; Alviano DS; Braga-Silva LA; Goulart FRV; Granato MQ; Rozental S; Alviano CS; Santos ALS; Kneipp LF
Front Microbiol; 2017; 8():918. PubMed ID: 28579986
[No Abstract] [Full Text] [Related]
3. HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis.
Santos LO; Marinho FA; Altoé EF; Vitório BS; Alves CR; Britto C; Motta MC; Branquinha MH; Santos AL; d'Avila-Levy CM
PLoS One; 2009; 4(3):e4918. PubMed ID: 19325703
[TBL] [Abstract][Full Text] [Related]
4. Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
Res Microbiol; 2006 Nov; 157(9):819-26. PubMed ID: 16959473
[TBL] [Abstract][Full Text] [Related]
5.
Palmeira VF; Goulart FRV; Granato MQ; Alviano DS; Alviano CS; Kneipp LF; Santos ALS
Front Microbiol; 2018; 9():1383. PubMed ID: 30008700
[No Abstract] [Full Text] [Related]
6. Aspartic peptidase of
Granato MQ; Sousa IS; Rosa TLSA; Gonçalves DS; Seabra SH; Alviano DS; Pessolani MCV; Santos ALS; Kneipp LF
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):629-638. PubMed ID: 32037904
[No Abstract] [Full Text] [Related]
7. Deletion of pksA attenuates the melanogenesis, growth and sporulation ability and causes increased sensitivity to stress response and antifungal drugs in the human pathogenic fungus Fonsecaea monophora.
Xiao X; Li Y; Lan Y; Zhang J; He Y; Cai W; Chen Z; Xi L; Zhang J
Microbiol Res; 2021 Mar; 244():126668. PubMed ID: 33359842
[TBL] [Abstract][Full Text] [Related]
8. Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy.
Santos LO; Garcia-Gomes AS; Catanho M; Sodre CL; Santos AL; Branquinha MH; d'Avila-Levy CM
Curr Med Chem; 2013; 20(25):3116-33. PubMed ID: 23298141
[TBL] [Abstract][Full Text] [Related]
9. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH
PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510
[TBL] [Abstract][Full Text] [Related]
10. The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.
Piccinini M; Rinaudo MT; Anselmino A; Buccinnà B; Ramondetti C; Dematteis A; Ricotti E; Palmisano L; Mostert M; Tovo PA
Antivir Ther; 2005; 10(2):215-23. PubMed ID: 15865215
[TBL] [Abstract][Full Text] [Related]
11. The major chromoblastomycosis fungal pathogen, Fonsecaea pedrosoi, extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key's host structures.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):21-9. PubMed ID: 16420593
[TBL] [Abstract][Full Text] [Related]
12. Silver(I) 1,10-Phenanthroline Complexes Are Active against
Sousa IS; Vieira TDP; Menna-Barreto RFS; Guimarães AJ; McCarron P; McCann M; Devereux M; Santos ALS; Kneipp LF
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983524
[TBL] [Abstract][Full Text] [Related]
13. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.
Santos AL; Palmeira VF; Rozental S; Kneipp LF; Nimrichter L; Alviano DS; Rodrigues ML; Alviano CS
FEMS Microbiol Rev; 2007 Sep; 31(5):570-91. PubMed ID: 17645522
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir.
Grigorian A; Hurford R; Chao Y; Patrick C; Langford TD
BMC Neurosci; 2008 Feb; 9():27. PubMed ID: 18302767
[TBL] [Abstract][Full Text] [Related]
15.
Breda LCD; Breda CNS; de Almeida JRF; Paulo LNM; Jannuzzi GP; Menezes IG; Albuquerque RC; Câmara NOS; Ferreira KS; de Almeida SR
Front Immunol; 2020; 11():540064. PubMed ID: 33193308
[TBL] [Abstract][Full Text] [Related]
16. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
[TBL] [Abstract][Full Text] [Related]
17. Ectophosphatase activity in conidial forms of Fonsecaea pedrosoi is modulated by exogenous phosphate and influences fungal adhesion to mammalian cells.
Kneipp LF; Rodrigues ML; Holandino C; Esteves FF; Souto-Padrón T; Alviano CS; Travassos LR; Meyer-Fernandes JR
Microbiology (Reading); 2004 Oct; 150(Pt 10):3355-62. PubMed ID: 15470114
[TBL] [Abstract][Full Text] [Related]
18. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
19. Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients.
Santos LO; Vitório BS; Branquinha MH; Pedroso e Silva CM; Santos AL; d'Avila-Levy CM
J Antimicrob Chemother; 2013 Feb; 68(2):348-53. PubMed ID: 23109184
[TBL] [Abstract][Full Text] [Related]
20. Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms.
Sangenito LS; Menna-Barreto RFS; Oliveira AC; d'Avila-Levy CM; Branquinha MH; Santos ALS
Int J Antimicrob Agents; 2018 Aug; 52(2):185-194. PubMed ID: 29635008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
